Wilson, J. M., & Fenoff, R. (2011). The health and economic effects of counterfeit pharmaceuticals in Africa.
Pharmaceutical counterfeiting in Africa remains a serious threat to quality health care and the African economy. An impairment to public health, counterfeit pharmaceuticals used to combat malaria and tuberculosis have been blamed for up to 700,000 deaths in Africa each year. They reduce the sales of legitimate drugs, reduce tax revenue, deter innovation and growth, discourage foreign investment, and require significant resources to combat them. Without empirical data on the different dimensions of the effects, the sheer magnitude of the problem is currently unknown because the estimates are not very reliable. Greater information on the problem is needed for developing evidence-based policy and decision making.
Also published in Global Edge Business Review at https://globaledge.msu.edu/content/gbr/gBR5-6.pdf.